NDC 0135-0300

ABREVA

Docosanol

ABREVA is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Docosanol.

• Product ID: 0135-0300_08951acc-d3e0-4629-b2b1-02d02a91d4af
• NDC: 0135-0300
• Product Type: Human Otc Drug
• Proprietary Name: ABREVA
• Generic Name: Docosanol
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2022-03-25
• Marketing Category: ANDA /
• Application Number: ANDA208754
• Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• Substance Name: DOCOSANOL
• Active Ingredient Strength: 100 mg/g
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0135-0300-01

1 TUBE in 1 PACKAGE (0135-0300-01) > 2 g in 1 TUBE

• Marketing Start Date: 2022-03-25
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ABREVA" or generic name "Docosanol"

NDC	Brand Name	Generic Name
0135-0200	ABREVA	docosanol
0135-0300	ABREVA	docosanol
50090-3476	ABREVA	ABREVA
30142-322	Cold Sore Fever Blister	Docosanol
0363-9220	Cold Sore Fever Blister Treatment	Docosanol
0363-9222	Cold Sore Fever Blister Treatment	Docosanol
11673-846	Cold Sore Fever Blister Treatment	Docosanol
11673-926	Cold Sore Fever Blister Treatment	Docosanol
11822-0951	Cold Sore Fever Blister Treatment	Docosanol
11822-3927	Cold Sore Fever Blister Treatment	Docosanol
11822-3951	Cold Sore Fever Blister Treatment	Docosanol
11822-3977	Cold Sore Fever Blister Treatment	Docosanol
11822-4763	Cold Sore Fever Blister Treatment	Docosanol
21130-823	Cold Sore Fever Blister Treatment	Docosanol
30142-981	Cold Sore Fever Blister Treatment	Docosanol
0363-2981	Docosanol	Docosanol
0472-2981	Docosanol	Docosanol
0591-2981	Docosanol	Docosanol
21130-422	Docosanol	Docosanol
21922-023	Docosanol	Docosanol